RAPA Therapeutics - ALS Trials, Expanded Access and Treatments

57:07
2025: New therapies and approaches in ALS : gene, small molecules, repair, and more

1:11:52
Pridopodine for treatment of ALS

57:02
Shifting the PARADIGM:PrimeC, an Oral Candidate for ALS

1:18:29
Repeat Associated Non-AUG (RAN) Proteins as Therapeutic Targets for C9orf72 ALS/FTD

1:18:37
Brain Computer Interface (BCI) Trials in ALS

1:04:29
#ExpertTalk: CNM-Au8 Long-term Evidence & EAP Program Update | Rob Etherington & Dr. Marjan Sepassi

1:16:12
Outcome Measures in ALS Clinical Trials

36:31